Avani Dave, Jai Hind College Ovarian cancer (OC) is among the most devastating gynaecological cancers, with high incidence and mortality rates across the world, putting women’s health and quality of life at risk. Although radical surgery and chemotherapy are two essential treatments for treating OC, they do not appear to diminish the high recurrence rate […]
Agrima Bhatt, Rajasthan University Many cancer patients are responsive to chemotherapy at the initial stages of treatment. Although, during treatment, they may develop resistance which makes cancer difficult to diagnose. This is of huge clinical concern in such sensitive treatments as it can later convert into huge barricades in patient’s lives. In clinical cancer treatment, […]
Avani Dave, Jai Hind College Background There are important modifications in how homogeneous neoplasms should be assessed and identified, which have considerable therapeutic implications and extensive biological interest. The fourth most prevalent cancer in children is non-Hodgkin lymphoma (NHL). The occurrence of NHL in the members within the family is known as familial NHL, which […]
Aqsa, Jamia Millia Islamia Cancer is a disease in which cells of the body grow abnormally and uncontrollably. Until now, there is still no permanent cure for cancer, but getting treatment for cancer might allow you to live for a certain period. Research for the cure of cancer has been underway for about 100 years […]
Sayak Banerjee, Amity University Kolkata Intra-tumor Heterogeneity ( ITH) Aggregation of a distinct set of somatic mutations leads to the generation of tumors. The set of mutations assembled by the prime tumor is known as clonal and the mutations which take place in pre-existing tumors comprise cancer cell sub-populations is known as subclonal. Consequently, the […]
Sayak Banerjee, Amity University Kolkata The scientists at the University of Leeds have discovered a new method of targeting a mutated protein, which is the reason behind most of the fatal cancers. The mutated form of RAS protein is often considered the “Death Star” since it has the potential to resist various treatments. Although RAS […]
Shayan Ahmed, Jamia Millia Islamia, New Delhi Cancer stem cells (CSCs) have recently been discovered in a number of different cancers, including pancreatic cancers. These are called pancreatic cancer stem cells (PCSCs). Pancreatic cancer is a frequently occurring cancer with a bad prognosis. Evidence suggests that sirtuin 1 (SIRT1) has biological activities that contribute to […]
Ananya Dutta, Bose Institute The contribution of several nutrients to cancer cells’ biosynthetic, bioenergetic, and antioxidant requirements has been intensively researched over the last decade. The connection between cancer genetics and metabolic rewiring, in particular, has resulted in significant findings, opening up new treatment avenues for certain cancer types. Clinicians are interested in how food […]
Ananya Dutta, Bose Institute This is the aphorism of Memorial Sloan Kettering (MSK) Cancer Center, New York, USA. At MSK it is believed that immunotherapy is one of the most promising treatments to treat, cure, and eventually prevent cancer. Immunotherapy cradled from MSK about more than a century ago. William Coley (1893), a surgeon at […]
Saptaparna Pal, Amity University Kolkata Some researchers from The Virginia School of Medicine have shed new light on how our brains mature; disclosing that the very last step in cell proliferation is important for the brain to reach its actual size and function. The new findings that are published in The Journal of Neuroscience identify […]
